Literature DB >> 26833270

Assessing the impact of a nurse-delivered home dried blood spot service on uptake of testing for household contacts of hepatitis B-infected pregnant women across two London trusts.

P Keel1, G Edwards1, J Flood1, G Nixon2, K Beebeejaun1, J Shute3, J Poh3, A Millar4, S Ijaz3, J Parry3, S Mandal1, M Ramsay1, G Amirthalingam1.   

Abstract

Despite national guidance recommending testing and vaccination of household contacts of hepatitis B-infected pregnant women, provision and uptake of this is sub-optimal. The aim of this study was to evaluate the use of in-home dried blood spot (DBS) testing to increase testing and vaccination of household contacts of hepatitis B-infected pregnant women as an alternative approach to conventional primary-care follow-up. The study was conducted across two London maternity trusts (North Middlesex and Newham). All hepatitis B surface antigen-positive pregnant women identified through these trusts were eligible for inclusion. The intervention of in-home DBS testing for household contacts was introduced at North Middlesex Trust from November 2010 to December 2011. Data on testing and vaccination uptake from GP records across the two trusts were compared between baseline (2009) and intervention (2010-2011) periods. In-home DBS service increased testing uptake for all ages (P < 0·001) with the biggest impact seen in partners, where testing increased from 30·3% during the baseline period to 96·6% during the intervention period in North Middlesex Trust. Although impact on vaccine uptake was less marked, improvements were observed for adults. The provision of nurse-led home-based DBS may be useful in areas of high prevalence.

Entities:  

Keywords:  Control; epidemiology; hepatitis B; immunization (vaccination); public health

Mesh:

Year:  2016        PMID: 26833270      PMCID: PMC9150565          DOI: 10.1017/S0950268815003325

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  8 in total

1.  EASL clinical practice guidelines: Management of chronic hepatitis B virus infection.

Authors: 
Journal:  J Hepatol       Date:  2012-03-20       Impact factor: 25.083

2.  Economic evaluation of infant and adolescent hepatitis B vaccination in the UK.

Authors:  M Ruby Siddiqui; Nigel Gay; W John Edmunds; Mary Ramsay
Journal:  Vaccine       Date:  2010-11-10       Impact factor: 3.641

3.  Factors associated with incomplete vaccination of babies at risk of perinatal hepatitis B transmission: a London study in 2006.

Authors:  Isabelle Giraudon; Nadia Permalloo; Grainne Nixon; Andre Charlett; Sandra Cohuet; Sema Mandal; Mary Ramsay; Bharat C Patel; Helen Maguire
Journal:  Vaccine       Date:  2009-01-09       Impact factor: 3.641

4.  Improving blood-borne viral diagnosis; clinical audit of the uptake of dried blood spot testing offered by a substance misuse service.

Authors:  N Craine; J Parry; J O'Toole; S D'Arcy; M Lyons
Journal:  J Viral Hepat       Date:  2008-09-26       Impact factor: 3.728

5.  Real-time PCR quantitation of hepatitis B virus DNA using automated sample preparation and murine cytomegalovirus internal control.

Authors:  J A Garson; P R Grant; U Ayliffe; R B Ferns; R S Tedder
Journal:  J Virol Methods       Date:  2005-06       Impact factor: 2.014

6.  The diversity and management of chronic hepatitis B virus infections in the United Kingdom: a wake-up call.

Authors:  Richard S Tedder; Alison J Rodger; Lori Fries; Samreen Ijaz; Mark Thursz; William Rosenberg; Nikolai Naoumov; Jangu Banatvala; Roger Williams; Geoffrey Dusheiko; Shilpa Chokshi; Terry Wong; Gillian Rosenberg; Sulleman Moreea; Margaret Bassendine; Michael Jacobs; Peter R Mills; David Mutimer; Stephen D Ryder; Andrew Bathgate; Hyder Hussaini; John F Dillon; Mark Wright; George Bird; Jane Collier; Michael Anderson; Anne M Johnson
Journal:  Clin Infect Dis       Date:  2012-12-07       Impact factor: 9.079

7.  Increasing the uptake of hepatitis C virus testing among injecting drug users in specialist drug treatment and prison settings by using dried blood spots for diagnostic testing: a cluster randomized controlled trial.

Authors:  M Hickman; T McDonald; Ali Judd; T Nichols; V Hope; S Skidmore; J V Parry
Journal:  J Viral Hepat       Date:  2007-12-11       Impact factor: 3.728

8.  Control of hepatitis B in the United Kingdom.

Authors:  M Ramsay; N Gay; K Balogun; M Collins
Journal:  Vaccine       Date:  1998-11       Impact factor: 3.641

  8 in total
  3 in total

Review 1.  Family Counseling for Hepatitis B and Hepatitis C.

Authors:  Tatyana Kushner; Rhoda S Sperling; Douglas Dieterich
Journal:  Clin Liver Dis (Hoboken)       Date:  2019-04-30

2.  Survey of programmatic experiences and challenges in delivery of hepatitis B and C testing in low- and middle-income countries.

Authors:  Azumi Ishizaki; Julie Bouscaillou; Niklas Luhmann; Stephanie Liu; Raissa Chua; Nick Walsh; Sarah Hess; Elena Ivanova; Teri Roberts; Philippa Easterbrook
Journal:  BMC Infect Dis       Date:  2017-11-01       Impact factor: 3.090

3.  Hepatitis B and C testing strategies in healthcare and community settings in the EU/EEA: A systematic review.

Authors:  Lauren M K Mason; Irene K Veldhuijzen; Erika Duffell; Ayla van Ahee; Eveline M Bunge; Andrew J Amato-Gauci; Lara Tavoschi
Journal:  J Viral Hepat       Date:  2019-08-16       Impact factor: 3.728

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.